Friday, November 16, 2012 4:09:25 PM
1. Market potential : top of the charts for any oncology treatment
2. Blockbuster potential (can't help repeat )
3. Relatively safer & easy pathway for FDA approval due to SPA/505(b) etc
4. China - First to submit with no reference approval required
5. HCC cases: 750k worldwide growing 5% every year. By 2020, it will be #1 cancer surpassing lung cancer
Lastly, MT, mentioned dose dependent PFS increase as much by a factor of 6 !
I bet the conference attendees must be excited as h*ll
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM